Moneycontrol PRO

Cadila Q2: Strong operational show backed by traction in COVID portfolio

In the next three years, Cadila plans to launch 45 injectables, which are expected to generate revenue of USD 150-200 million at peak

November 03, 2020 / 02:02 PM IST
Cadila Q2: Strong operational show backed by traction in COVID portfolio

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Q2 performance led by volume growth in US - Cadila’s COVID vaccine undergoing phase II trials - Strong entry into injectables, biologics – a key watch - Growing India presence provides steady cash flow visibility Cadila Healthcare (CMP: Rs 410, Market cap: Rs 41,988 crore) - one of India’s formidable plays on COVID solutions – has come out as a key beneficiary of the demand for Remdesivir. It is the only US FDA approved drug under the Emergency Use Authorization (EUA) for the treatment of mild...

  • PRO Panorama

    Moneycontrol Pro Panorama | Take guard, expect more swings in the market

    Dec 8, 2021 / 03:06 PM IST

    In today’s edition of Moneycontrol Pro Panorama: RBI plays it safe, what financial conditions index says, how India’s wealthy invests, taper talk gets louder, Shriram Properties IPO, four Indias and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Transitory is history

    Dec 4, 2021 / 10:09 AM IST

    As inflation remains persistently high, the Fed looks to double down on the taper despite the emergence of Omicron

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers